(PharmaNewsWire.Com, August 15, 2020 ) The global patient lifting equipment market size is expected to grow from USD 3.0 billion in 2019 to USD 5.4 billion by 2024, at a CAGR of 12.7% during the forecast period. The growth of this market is driven primarily by factors such as the rising global geriatric & bariatric populations, the high risk of injuries to caregivers during the manual handling of patients, and the implementation of regulations ensuring the safety of healthcare personnel during manual lifting.
The major players in the patient lifting equipment market include Arjo (Sweden), Hill-Rom (US), Invacare (US), Handicare (Sweden), and Guldmann (US). These players have adopted various growth strategies such as product launches & product upgrades, acquisitions, partnerships & collaborations, and expansion to increase their presence in the global patient lifting equipment industry.
Hill Rom (US) was one of the major players operating in the patient lifting equipment market in the year 2018. The company has a wide range of product offerings in this market. To maintain its market position, the company mainly focuses on new developments by making significant investments in R&D. In 2018, the company invested about USD 0.4 billion in R&D, which accounted for (4.8%) of its total revenue. The company mainly focuses on new product developments, which enabled them for product innovation and ultimately helped to enhance its product offerings for the patient lifting equipment market.
Arjo (Sweden) is among the leading players in the patient lifting equipment market. Arjo’s major customers include private and public institutions providing acute and long-term care. The company has a strong global geographic presence, which has helped it broaden the sales and distribution of patient lift market. Approximately 23% of Arjo’s total sales are attributed to its patient handling equipment portfolio. The company has a wide range of product offerings, which includes ceiling lifts, standing and raising aids, floor lifts, and slings.
About MarketsandMarkets™
MarketsandMarkets™ provides quantified B2B research on 30,000 high growth niche opportunities/threats which will impact 70% to 80% of worldwide companies’ revenues. Currently servicing 7500 customers worldwide including 80% of global Fortune 1000 companies as clients. Almost 75,000 top officers across eight industries worldwide approach MarketsandMarkets™ for their painpoints around revenues decisions.
Our 850 fulltime analyst and SMEs at MarketsandMarkets™ are tracking global high growth markets following the "Growth Engagement Model – GEM". The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write "Attack, avoid and defend" strategies, identify sources of incremental revenues for both the company and its competitors. MarketsandMarkets™ now coming up with 1,500 MicroQuadrants (Positioning top players across leaders, emerging companies, innovators, strategic players) annually in high growth emerging segments. MarketsandMarkets™ is determined to benefit more than 10,000 companies this year for their revenue planning and help them take their innovations/disruptions early to the market by providing them research ahead of the curve.
MarketsandMarkets’s flagship competitive intelligence and market research platform, "Knowledgestore" connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets.
We are pleased to offer you this exciting, new, and entirely free professional resource. Visit our Free Biotechnology & Pharmaceuticals resource center today to browse our selection of 600+ complimentary Biotechnology & Pharmaceuticals magazines, white papers, webinars, podcasts, and more. Get popular titles including:
